Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,040.00
-95.00 (-4.45%)
Nov 15, 2024, 9:00 AM KST

Kangstem Biotech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-9,765-21,949-20,236-21,348-18,471-24,635
Upgrade
Depreciation & Amortization
3,7363,9153,8713,8742,9942,097
Upgrade
Loss (Gain) From Sale of Assets
-10,014-95.525.6-1,27219.19-
Upgrade
Asset Writedown & Restructuring Costs
250.52250.52--1,7524,707
Upgrade
Loss (Gain) From Sale of Investments
782.87151.81308.46348.21-298-2,022
Upgrade
Loss (Gain) on Equity Investments
660.13720.33---563.07
Upgrade
Stock-Based Compensation
-274.361,059862.04-104.44123.16
Upgrade
Provision & Write-off of Bad Debts
-263.03-263.03-144.01-192.74-229.55877.15
Upgrade
Other Operating Activities
-426.16-505-124.4348.05-1,499-1,409
Upgrade
Change in Accounts Receivable
-279.561,109-198.26-371.57-74.22939.07
Upgrade
Change in Inventory
213.19-68.88334.59-534.59153.96883.06
Upgrade
Change in Accounts Payable
1,366-10.33-443.81464.96-241.4-1,170
Upgrade
Change in Other Net Operating Assets
-2,042-27.07-3,296828.262,0055,725
Upgrade
Operating Cash Flow
-15,780-16,498-18,864-16,994-13,994-13,322
Upgrade
Capital Expenditures
-1,449-1,392-712.42-4,631-3,038-15,342
Upgrade
Sale of Property, Plant & Equipment
1012819.362.2746.61-
Upgrade
Sale (Purchase) of Intangibles
559.09542.2-135.06-19.42-15.59-1,723
Upgrade
Investment in Securities
-6,490-1,49617,103-22,95532,839-21,200
Upgrade
Other Investing Activities
114.1813.66-39.022,82817.06134.9
Upgrade
Investing Cash Flow
-6,345-2,30416,236-24,77529,849-38,131
Upgrade
Long-Term Debt Issued
-3801,1001,830-5,400
Upgrade
Total Debt Issued
1,8803801,1001,830-5,400
Upgrade
Long-Term Debt Repaid
--923.48-1,568-918.89-13,298-2,170
Upgrade
Total Debt Repaid
-689.71-923.48-1,568-918.89-13,298-2,170
Upgrade
Net Debt Issued (Repaid)
1,190-543.48-468.3911.11-13,2983,230
Upgrade
Issuance of Common Stock
20,52120,521236.738,377193.5547,779
Upgrade
Other Financing Activities
0.1-00.21-2.4-462.872.27
Upgrade
Financing Cash Flow
21,71019,977-231.439,286-13,56755,911
Upgrade
Foreign Exchange Rate Adjustments
0.160.07-1.3355.47--
Upgrade
Miscellaneous Cash Flow Adjustments
-0---000
Upgrade
Net Cash Flow
-414.221,175-2,861-2,4272,2884,459
Upgrade
Free Cash Flow
-17,229-17,890-19,576-21,624-17,033-28,664
Upgrade
Free Cash Flow Margin
-129.76%-140.82%-120.10%-174.32%-186.39%-477.37%
Upgrade
Free Cash Flow Per Share
-347.33-440.63-516.01-776.52-763.89-1375.45
Upgrade
Cash Interest Paid
523.78567.02364211.46248.5239.8
Upgrade
Cash Income Tax Paid
0.4273.0273.21-65.945.67135.84
Upgrade
Levered Free Cash Flow
-10,255-9,991-13,595-15,281-10,731-25,257
Upgrade
Unlevered Free Cash Flow
-9,707-9,432-13,119-14,806-10,380-24,584
Upgrade
Change in Net Working Capital
-437.89-1,6143,792193.39-1,492-4,747
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.